These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 20490957

  • 1. Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid.
    Wang S, Xu H, Xu J, Zhang Y, Liu Y, Deng YH, Chen D.
    AAPS PharmSciTech; 2010 Jun; 11(2):870-7. PubMed ID: 20490957
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. PEGylated hyaluronidase/NIR induced drug controlled release system for synergetic chemo-photothermal therapy of hepatocellular carcinoma.
    Li H, Li H, Yu W, Huang S, Liu Y, Zhang N, Yuan J, Xu X, Duan S, Hu Y.
    Eur J Pharm Sci; 2019 May 15; 133():127-136. PubMed ID: 30779981
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells.
    Garg M, Madan J, Pandey RS, Sardana S, Katyal A, Chandra R.
    Anticancer Drugs; 2012 Sep 15; 23(8):836-45. PubMed ID: 22407250
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies.
    Xiao P, Zhao J, Huang Y, Jin R, Tang Z, Wang P, Song X, Zhu H, Yang Z, Yu N.
    Pharm Nanotechnol; 2020 Sep 15; 8(5):391-398. PubMed ID: 32787769
    [Abstract] [Full Text] [Related]

  • 11. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo.
    Sun M, Wang Y, Shen J, Xiao Y, Su Z, Ping Q.
    Nanotechnology; 2010 Nov 26; 21(47):475101. PubMed ID: 21030757
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel Galactosylated Poly(ethylene glycol)-Cholesterol for Liposomes as a Drug Carrier for Hepatocyte-Targeting.
    Zhang H, Xiao Y, Cui S, Zhou Y, Zeng K, Yan M, Zhao C.
    J Nanosci Nanotechnol; 2015 Jun 26; 15(6):4058-69. PubMed ID: 26369013
    [Abstract] [Full Text] [Related]

  • 16. Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells.
    Gu YJ, Cheng J, Jin J, Cheng SH, Wong WT.
    Int J Nanomedicine; 2011 Jun 26; 6():2889-98. PubMed ID: 22131835
    [Abstract] [Full Text] [Related]

  • 17. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.
    Wei M, Guo X, Tu L, Zou Q, Li Q, Tang C, Chen B, Xu Y, Wu C.
    Int J Nanomedicine; 2015 Jun 26; 10():5123-37. PubMed ID: 26316745
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
    Xiang G, Wu J, Lu Y, Liu Z, Lee RJ.
    Int J Pharm; 2008 May 22; 356(1-2):29-36. PubMed ID: 18258394
    [Abstract] [Full Text] [Related]

  • 19. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS, Silva JO, Monteiro LOF, Leite EA, Cassali GD, Rubello D, Cardoso VN, Ferreira LAM, Oliveira MC, de Barros ALB.
    Biomed Pharmacother; 2016 Dec 22; 84():252-257. PubMed ID: 27664949
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes.
    Arima H, Hagiwara Y, Hirayama F, Uekama K.
    J Drug Target; 2006 May 22; 14(4):225-32. PubMed ID: 16777681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.